Cyclo Therapeutics, Inc.
CTD Holdings, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company's Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C, a rare and fatal genetic disease. Additional indications for the active ingredient in Trappsol® Cyclo™, are in development.
Whom to Contact
- Jeffrey TatePhone: (386) 418-8060
Search for CTD Holdings on google maps - it is updated.